Acorda halts enrollment in Parkinson's trial, shares plunge

(Reuters) - Acorda Therapeutics Inc's shares plunged 34 percent on Wednesday after the drugmaker said it had paused enrolling patients in two key trials testing its Parkinson's disease drug following patient deaths.

from Reuters: Health News http://reut.rs/2AJP7ci